SARS-CoV-2 envelope protein, Rabbit Polyclonal Antibody

As low as US$477.00
Only %1 left
Catalog Number
R-1959

    Product Info

  • Product Name SARS-CoV-2 envelope protein, Rabbit Polyclonal Antibody
  • Product Description google Rabbit anti-SARS-CoV-2 envelope protein Polyclonal Antibody (Unconjugated), suitable for ELISA.
  • Alternative Names SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Envelope protein, E protein
  • Application(s) ELISA
  • Antibody Host Rabbit
  • Antibody Type Polyclonal
  • Specificity Predicted reactivity based on immunogen sequence: SARS-CoV Envelope proteins: (100%)
  • Species Reactivity Virus
  • Immunogen Description Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody (R-1959-100) was raised against a peptide corresponding to 10 amino acids near the amino terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein.

    The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope.
  • Conjugate Unconjugated
  • Concentration 1 mg/mL
  • Purity Description Affinity-purified via peptide column.
  • Regulatory Status For research use only.

    Specifications

  • Product Description Rabbit anti-SARS-CoV-2 envelope protein Polyclonal Antibody (Unconjugated), suitable for ELISA.
  • Application(s) ELISA
  • Application Details SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody can be used for the detection of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein in ELISA. It will detect 20 ng of free peptide at 1 μg/mL.
  • Target SARS-CoV-2 envelope protein
  • Specificity Predicted reactivity based on immunogen sequence: SARS-CoV Envelope proteins: (100%)
  • Target Host Species Virus
  • Species Reactivity Virus
  • Antibody Host Rabbit
  • Antibody Type Polyclonal
  • Antibody Isotype IgG
  • Conjugate Unconjugated
  • Immunogen Description Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody (R-1959-100) was raised against a peptide corresponding to 10 amino acids near the amino terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein.

    The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope.
  • Homology Predicted reactivity based on immunogen sequence: SARS-CoV Envelope proteins: (100%)
  • Isoform Information SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope has one isoform (75aa).
  • Purity Description Affinity-purified via peptide column.
  • Format Liquid. SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody is supplied in PBS containing 0.02% sodium azide. Conc.1 mg/mL
  • Concentration 1 mg/mL
  • Reconstitution Instructions Spin vial briefly before opening.
  • Storage Instructions SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody can be stored at 2-8°C for three months and -20 ° C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Batch Number Please see item label.
  • Expiration Date 12 months after date of receipt (unopened vial).
  • Alternative Names SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Envelope protein, E protein
  • Uniprot Number P0DTC4
  • Uniprot Number/Name P0DTC4 (VEMP_SARS2)
  • NCBI Official Full Name envelope protein
  • NCBI Official Symbol E
  • NCBI Organism SARS-CoV-2
  • Scientific Background Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication (3).
  • Research Area Infectious Disease
  • Shipping Temperature 2-8°C (on cold packs)
  • UNSPSC CODE 41116161
  • Regulatory Status For research use only.

    Images, Protocols & SDS

  • Figure 1 ELISA Test
    Antibodies: SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody, R-1959-100 (1 μg/mL). A direct ELISA was performed using antigen or control peptide as coating antigen and the anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 32 ng/mL to 2000ng/mL.

    Citations & References

  • General References Gorbalenya. bioRxiv: 2020.
    Hui et al. Int J Infect Dis. 2020;91:264-266.
    Pervushin et al. PLoS Pathog. 2009; 5(7): e1000511.